VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0953078
Sex: F
Age:
State: TX

Vax Date: 12/31/2020
Onset Date: 01/04/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Heart fluttering; chest pressure; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: EK5730; expiration date: not known), via an unspecified route of administration in the left arm at hospital on 31Dec2020 10:00 at at single dose for COVID-19 immunization. Medical history included known allergies with sulfa. The patient is not pregnant. The patient's concomitant medications were not reported. The patient previously took clarithromycin (BIAXIN), metronidazole benzoate (FLAGYL), and sulfamethoxazole, trimethoprim (BACTRIM), and all but experienced allergies (reported as "known allergies: Biaxin, Flagyl, sulfa, Bactrim"). No COVID prior to vaccination and no COVID tested post vaccination. The patient experienced heart fluttering and chest pressure on 04Jan2021. There was no treatment received for the reported events. The outcome of the events was not recovered.; Sender's Comments: A causal relationship between the reported heart fluttering and the use of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded due to temporal relationship. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953079
Sex: F
Age: 58
State: CO

Vax Date: 01/07/2021
Onset Date: 01/15/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies: Sulfa

Symptoms: Sore arm first 3 days, reported on V-Safe. That was only reaction. The after 1 week, Fri. arm started to hurt again, then itch and turned red around injection area for several days. Took Photo if needed.

Other Meds: Vitaman C,D B Complex, E , Fish Oil, Calcium

Current Illness: NONE

ID: 0953080
Sex: F
Age:
State: NC

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Fever up; Result Unstructured Data: Test Result:up to 102; Test Date: 20210108; Test Name: Tachycardia; Result Unstructured Data: Test Result:150; Comments: Tachycardia up to 150 resting

Allergies:

Symptoms: Tachycardia up to 150 resting; Nausea; Vomiting; Diarrhea; Headache; Migraine; Body aches; Chills; Fever up to 102; This is a spontaneous report from a contactable nurse (patient). This 26-year-old female patient (pregnant: no) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3248), intramuscular on 08Jan2021 at 07:45 AM at single dose on right arm for COVID-19 immunisation. Medical history included anxiety and depression. No known allergies. Concomitant medication included fluoxetine hydrochloride (PROZAC), bupropion hydrochloride (WELLBUTRIN), diphenhydramine hydrochloride (ZZZQUIL). No other-vaccine-in-four weeks. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EK5730), intramuscular on 22Dec2020 at 08:00 PM on right arm for COVID-19 immunisation. The patient experienced tachycardia up to 150 resting, nausea, vomiting, diarrhea, headache, migraine, body aches, chills and fever up to 102. Symptom onset around 7PM on 08Jan2021 and stopped around 12PM 09Jan2021 except for headache which was still persisting as of 9PM 09Jan2021. No treatment was received for the events. The outcome of headache was not recovered. The outcome of other events was recovered on 09Jan2021 at 12PM. The patient did not have COVID-prior-vaccination. The patient did not have COVID tested post vaccination.; Sender's Comments: The reported tachycardia was probably related to the use of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) due to temporal relationship. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: PROZAC; WELLBUTRIN; ZZZQUIL

Current Illness:

ID: 0953081
Sex: M
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bell's palsy onset within 48 hours of second vaccine, R side of face; First dose of vaccine on 20Dec2020 and second dose received on 06Jan2021; First dose of vaccine on 20Dec2020 and second dose received on 06Jan2021; This is a spontaneous report from a contactable healthcare professional reporting for himself from a Pfizer sponsored program. A 24-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EJ1686) via an unspecified route of administration, on 06Jan2021 at 11:30am on left arm, single dose for COVID-19 immunization. Relevant medical history and concomitant medications were reported as none. The patient had no known allergies. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL0140) at right arm on 20Dec2020 10:30am for COVID-19 immunization. On 08Jan2021 at 12:00pm, the patient experienced facial droop 2 days after taking the 2nd dose of the vaccine. The patient went to the hospital for doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and were advised to take Valtrex and Prednisone and told its Bell's palsy. Bell's palsy onset within 48 hours of second vaccine, R side of face. Wanted to confirm if there will be a problem once they take these drugs since the paient have just received the vaccine recently or wanted to know if the new medications prescribed will affect the vaccine's effectivity. The patient was not diagnosed with COVID prior vaccination and was not tested for COVID post vaccination. Outcome of the event Bell's palsy was not recovered.; Sender's Comments: Facial droop/ Bell's palsy occurred 2 days after taking the 2nd dose of the BNT162B2 vaccine, a possible causal association between administration of BNT162B2 and the event onset thus might not be fully excluded, considering the plausible temporal relationship. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953082
Sex: F
Age: 36
State: CA

Vax Date: 01/08/2021
Onset Date: 01/18/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: Red ring around area where vaccine was given approximately 7cm x 7cm. Skin is hot to touch, swollen, itchy, nerve pain up and down shoulder and arm.

Other Meds: Escitalopram Wellbutrin Xanax Nexium Docusate Sodium Blisovi-Fe 1/20 Fiber Gummies

Current Illness: None

ID: 0953083
Sex: F
Age:
State: AZ

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: Covid test/ Nasal Swab; Result Unstructured Data: Test Result:Pending

Allergies:

Symptoms: 7 days later diagnosed with pneumonia; 3 days after developed hives on my stomach and arm; felt tired; confused; unwell; This is a spontaneous report from a contactable healthcare professional (patient). A 37-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek5730), via an unspecified route of administration on the left arm on 28Dec2020 12:00PM at a single dose for COVID-19 immunization at hospital facility. Medical history included Hashimotos disease. The patient had no known allergies and has not had COVID prior to vaccination. The patient's concomitant medications were not reported. The patient reported that she felt tired and confused and unwell on day of injection, 28Dec2020. After three days (31Dec2020), she developed hives on her stomach and arm and seven days later (04Jan2021), she was diagnosed with pneumonia and continued to have hives all over her legs and arms to this day. The patient was treated with antibiotics for pneumonia. She underwent Covid test/ Nasal swab post vaccination on 09Jan2021, pending result. The outcome of the events was not recovered.; Sender's Comments: The reported pneumonia was more likely an intercurrent disease, and unlikely causally related to the use of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE). The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953084
Sex: F
Age:
State: MO

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: difficult breathing; Pain on the chest; Not being able to move my upper neither lower body; itchiness all over my body; unconscious; Headaches; major anxiety; depression; very light-headed; weak; almost faint; This is a spontaneous report from a contactable Other HCP (patient). A 28-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 12:00 at single dose on Left arm for COVID-19 immunisation. Facility type vaccine was Hospital. Medical history was none. The patient's concomitant medications were not reported. No other vaccine in four weeks. The patient experienced Not being able to move my upper neither lower body, Headaches, major anxiety, and depression, unconscious, very light-headed, weak, almost faint, Pain on the chest, difficult breathing, itchiness all over my body on 08Jan2021. AEs resulted in Emergency room/department or urgent care, Hospitalization. Received injected fluids as treatment. The outcome was Not Recovered. No COVID prior vaccination. No COVID tested post vaccination. Information on the lot/ batch number has been requested.; Sender's Comments: Based on a close temporal association, a causal relationship between reported events and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953085
Sex: F
Age: 24
State: MN

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: NA

Allergies: Allergic to melons(watermelon, cantaloupe)

Symptoms: Dizzy, nauseous, fainted, emesis, severe sweating from 6am-8:30am

Other Meds: Sertraline, omeprazole

Current Illness: None

ID: 0953086
Sex: F
Age:
State: TN

Vax Date: 12/19/2020
Onset Date: 12/19/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I had a very early miscarriage at five weeks; I had a very early miscarriage at five weeks; I had a very early miscarriage at five weeks; This is a spontaneous report from a contactable Physician (patient). A 31-year-old female patient received BNT162B2 first dose of (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJI685) intramuscular at arm right on 19Dec2020 06:30 at single dose for covid-19 immunization. Facility type vaccine was hospital. Medical history was none. The patient had no known allergies or other medical history. There were no concomitant medications. No other vaccine in four weeks and no other medications in two weeks. The patient experienced a very early miscarriage at five weeks on 01Jan2021. The event result in doctor or other healthcare professional office/clinic visit. No treatment received. The outcome of the event miscarriage was recovered in Jan2021. No covid prior vaccination and no covid tested post vaccination.; Sender's Comments: All pregnancies have a risk of birth defect, loss, or other adverse outcomes. The data on BNT162B2 administered to pregnant women is insufficient to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953087
Sex: F
Age:
State: PA

Vax Date: 12/01/2020
Onset Date: 01/05/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: heart rate; Result Unstructured Data: Test Result:elevated; Test Date: 20210106; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: almost pass out; Chills; nausea; diarrhea; abdominal pain; clammy; elevated heart rate; dizzy; This is a spontaneous report from a contactable consumer (patient's parent). A 24-year-old female patient (pregnant: No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) via an unspecified route of administration on left arm on an unspecified date in Dec2020 at single dose for COVID-19 immunization. The relevant medical history included asthma, migraines and anxiety all from an unspecified date. Concomitant medications included ethinylestradiol, etonogestrel (NUVARING), topiramate (TOPAMAX), verapamil and sertraline hydrochloride (ZOLOFT). The patient experienced chills, nausea, diarrhea, abdominal pain, clammy, elevated heart rate, almost pass out, dizzy, all on 05Jan2021. The patient had no treatment for the events. No covid prior vaccination. The patient underwent lab test included heart rate showed elevated on 05Jan2021, Nasal Swab showed negative on 06Jan2021. The outcome of the events was not recovered.

Other Meds: NUVARING; TOPAMAX; ; ZOLOFT

Current Illness:

ID: 0953088
Sex: M
Age: 35
State: NY

Vax Date: 01/08/2021
Onset Date: 01/18/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Got covid after 10days, with signs and symptoms

Other Meds: Metformin, simvastatin

Current Illness:

ID: 0953089
Sex: F
Age:
State: TN

Vax Date: 01/05/2021
Onset Date: 01/10/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash on lower legs similar to that seen with Thrombocytopenia.; Rash on lower legs similar to that seen with Thrombocytopenia.; This is a spontaneous report from a contactable Other HCP (patient). A 21-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number= EJ1686), via an unspecified route of administration at Left arm on 05Jan2021 10:00 AM at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. The patient's medical history and concomitant medications were unknown. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced rash on lower legs similar to that seen with thrombocytopenia on 09Jan2021 at time of 12:00 PM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was not recovered.; Sender's Comments: A possible contributory effect of suspect drug on reported thrombocytopenia cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953090
Sex: F
Age:
State: AZ

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigued; Sore in her throat; Lost her voice (hoarse); Reddish nose; Intermittent coughs; she went to work to a COVID unit which she usually didn't do; described her symptoms as a chest cold; Feeling strange like coming down; swelling and soreness in the injection site for a day or two; swelling and soreness in the injection site for a day or two; This is a spontaneous report from a contactable nurse reported for self. This 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via unspecified route of administration on 07Jan2021 13:30 PM at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not provided. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) for COVID-19 immunization on an unspecified date. On 07Jan2021 after second dose vaccination, the patient started experiencing swelling and soreness in the injection site for a day or two. On 08Jan2021 the next day, she went to work to a COVID unit which she usually didn't do. On 08Jan2021 the next day after her shift at 15:00 PM, she started feeling strange like coming down. On 09Jan2021, she felt totally fatigued. The symptom that bothered her the most is the sore in her throat which has gone 10Jan2021, she said she lost her voice (hoarse). She was also experiencing a reddish nose and intermittent coughs. She described her symptoms as a chest cold. The patient also stated she didn't have fever or chills. She's afraid she might be sick. The outcome of event the sore in her throat was resolved on 10Jan2021. The outcome of other events was unknown. Information about lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported chest cold cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953091
Sex: U
Age: 27
State: IN

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Not yet pending associates allergist visit

Allergies: Fish, bananas, alvacado, lavendar

Symptoms: Right side of face including lips are numb starting at 11:55 a.m. Have phone call into associates PCP. In care of co workers. Associate is alert and oriented. Appointment with associates allergist at 4:00 p.m. today

Other Meds: Paxil 10 mg/daily, Zyrtec 10 mg/day. Multilvitiman

Current Illness: None

ID: 0953092
Sex: F
Age:
State: WY

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tingling sensation in right eye and mid cheek area,Unable to wink, or scrunch right eye; muscles on the right side of my face were noticeably weaker; This is a spontaneous report from a contactable nurse (patient). This 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EH9899), via an unspecified route of administration, on 23Dec2020 at 04:00 PM at single dose for COVID-19 immunisation. Vaccine location was right arm. The patient was vaccinated at Public Health Clinic/Veterans Administration facility, age at vaccination was 48-years-old. No other vaccine was received in four weeks. Medical history included gastrooesophageal reflux disease (GERD). Known allergies included levofloxacin (LEVOFLOXACIN), pethidine hydrochloride (DEMEROL), phenobarbital, cefalexin monohydrate (KEFLEX), charithromycin (BIAXIN). Concomitant medications included dexlansoprazole (DEXILANT), estradiol, phentermine, ergocalciferol (VIT D), calcium. The patient was not tested for covid prior or post vaccination. On 23Dec2020 at 04:45 PM, after leaving the clinic, the patient felt tingling sensation in right eye and mid cheek area. Within 1.5 hours, muscles on the right side of her face were noticeably weaker. Unable to wink, or scrunch right eye. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient was treated with prednisone. Outcome was recovering.; Sender's Comments: Based on a close temporal relationship causality between events "tingling sensation in right eye and mid cheek area" and "muscles on the right side of her face were noticeably weaker" and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: DEXILANT; ; ; VIT D;

Current Illness:

ID: 0953093
Sex: F
Age:
State: AR

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptoms: She is still freezing to death; Sick as a dog; Fever; Chills; cannot eat and have no appetite; nauseous; This is a spontaneous report from a contactable nurse (patient). A 79-year-old female patient received first dose of bnt162b2 (also reported as Pfizer Covid vaccine, lot number: EK4176), intramuscular into left arm on 05Jan2021 16:00 at single dose indicated as presentation because she is a nurse/Covid-19 immunization. Medical history included Type 2 Diabetes, about 2 years ago in 2019 in which she takes metformin 1,000mg twice daily. Concomitant medication included metformin on unspecified date at 1,000mg twice daily for Type 2 Diabetes. There was no history of all previous immunization with the Pfizer vaccine nor there were additional vaccines administered on same date of the Pfizer Covid vaccine. The patient received the Pfizer COVID vaccine last Tuesday and since 06Jan2021 at 06:00, she has been sick as a dog. She is running a fever, has chills, can't eat and has no appetite because she is nauseous; all on 06Jan2021 at 06:00. This is the third day of it. She would like to know what she can she do. She said that it all started Wednesday morning when she got up. It just gets worse every day. It looks like it would get better by now, but it hasn't. She never runs a temperature, but she has now (unspecified date). She is still freezing to death on unspecified date. She usually has a good appetite. Even the thought of food makes her sick. She further reported that she has had nothing but chills, fever, and nausea and states it will not go away. She is treating it with ibuprofen. She confirms she already talked to a nurse in this department to report this and she was transferred to see what she could do and states they never answered. This is her first dose and she does not know if she should get the second dose. The patient can't calm down since she has been sick since last Wednesday. She stated that she needed some help because she is so sick. She was suggested to call again calling Pfizer medical information department. She stated that she had called back three times, but there is no such number. The events sick as a dog, fever, chills, can't eat and has no appetite, and nauseous were considered serious (Other medically important condition). The outcome of the events sick as a dog, fever, chills, can't eat and has no appetite, and nauseous was not recovered, and the outcome of the remaining event was unknown.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be completed based on known safety profile and a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953094
Sex: F
Age: 38
State: NJ

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies: NKA

Symptoms: BODY ACHES; MUSCLE ACHES; LOWER BACK PAIN; HEADACHE. TOOK TYLENOL

Other Meds: NONE

Current Illness: NONE

ID: 0953095
Sex: F
Age:
State: MA

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: palms of my hands were bright red; very warm flush feeling; nausea; swelling of the throat; rash on my arms and abdomen; This is a spontaneous report from a contactable nurse (patient). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899 and expiration date not provided), intramuscular in the left arm on 06Jan2021 16:00 (at the age of 49 years old) at a single dose for COVID-19 immunization. Medical history included psoriasis, microscopic colitis, allergies to shellfish, and coconut. The patient's concomitant medications were not reported. The patient previously took estrogen patch, etanercept (ENBREL) and sulfamethoxazole, trimethoprim (BACTRIM) and experienced allergies to all. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine and did not take any other medications with 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 06Jan2021 16:15, the patient experienced a very warm flush feeling, nausea started and by 15 minutes, she had swelling of the throat and rash on her arms and abdomen and the palms of her hands were bright red. The events resulted in Emergency room/department or urgent care visit. The patient was treated with diphenhydramine hcl (BENADRYL), steroids (unspecified), famotidine (PEPCID) and ondansetron (ZOFRAN) in response to the events. The patient assessed the events as non-serious. The outcome of the events was recovered with sequel on an unspecified date in Jan2021. The patient has not been tested for COVID-19 since the vaccination.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953096
Sex: F
Age: 31
State: TX

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I developed redness, warmth, swelling, and tenderness at the site that has gradually worsened over the past week. Today (1-07-21) I am also experiencing itching at the site. I am going to try some Benadryl and Zyrtec in case this is an allergic reaction.

Other Meds:

Current Illness:

ID: 0953097
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: glaucoma; This is spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) via unspecified route of administration on unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first shot and was scheduled to receive the second dose on 27Jan2021 however, she has an eye surgery for glaucoma scheduled on 22Jan2021 and 25Jan2021. The patient wanted to know if she re-schedule the eye surgery. The outcome of the event glaucoma was unknown. Follow-up activities are possible, information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0953098
Sex: F
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Stevens Johnson Syndrome; rash was starting to peel; developed a rash all over her neck/ the rash has spread to face eyes, cheek; developed a rash all over her neck, "looks like its peeling and taut"; developed a rash all over her neck, "looks like its peeling and taut"; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age (Age: 48, Unit unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10Jan2021 at single dose for covid-19 immunization. Medical history included she had an allergic reaction to sulfa and developed Stevens Johnson syndrome from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced Stevens Johnson Syndrome, developed a rash all over her neck/ the rash has spread to face eyes, cheek; "looks like its peeling and taut"; and the rash was starting to peel, all in Jan2021. The patient received 1st dose of vaccine on 10Jan2021, developed a rash all over her neck, "looks like its peeling and taut". She had an allergic reaction to sulfa and developed Stevens Johnson syndrome, this looks similar to that (Experience of Stevens Johnson Syndrome). The patient was asking if she did take the steroid dose pack from her dermatologist for the skin rash will it prohibit her from taking the second dose of the vaccine. She called yesterday and reported a rash after receiving the first dose of the COVID-19 vaccine. She stated that she went to her Dermatologist this morning because the rash has spread to face eyes, cheek and the rash was starting to peel. She stated that the dermatologist wanted to know if it was safe to treat her with a prednisone dose pack after receiving the vaccine. Her rash was worsening so she went to her dermatologist for treatment. She was asking if she should get the second dose. The outcome of events for developed a rash all over her neck/ the rash has spread to face eyes, cheek was not resolved, for other events was unknown. Information about lot/batch number has been requested.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of suspect Stevens Johnson Syndrome presented as skin reactions cannot be excluded, considering the plausible temporal relationship. Severe allergic reaction is the known risk for the vaccine. The underlying predisposing condition of an allergic reaction to sulfa developed Stevens Johnson syndrome may put the patient at high risk of the similar occurrence. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate

Other Meds:

Current Illness:

ID: 0953099
Sex: F
Age:
State: MI

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: HR; Result Unstructured Data: Test Result:increased

Allergies:

Symptoms: following day around 7pm lip swelling; tongue tingling; body hives; chills; After first dose of Covid vaccine face flushing; increased HR about 45 mins. went away on its own; hours later left eye swollen; This is a spontaneous report from a contactable Nurse (patient). A 31-years-old female patient received first dose of bnt162b2 (BNT162B2, Lot number: EK9231), via an unspecified route of administration on 06Jan2021 15:00 at single dose on Left arm for covid-19 immunisation. Medical history included Known allergies: Shellfish, IV contrast dye, Penicillin. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. The patient experienced after first dose of covid vaccine face flushing; increased hr about 45 mins. went away on its own since 06Jan2021 16:00; hours later left eye swollen on 06Jan2021; following day around 7pm lip swelling, tongue tingling, body hives, chills on 07Jan2021 19:00. The patient underwent lab tests and procedures which included heart rate: increased on Jan2021. Ae resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Ae treatment: Steroids, IV fluids, Benadryl. No COVID prior vaccination. No COVID tested post vaccinate. This report was reported non-serious. The event outcome of increased hr about 45 mins. went away on its own was recovered on 06Jan2021 16:45, outcome of other events were not recovered.; Sender's Comments: Based on the compatible time association, the serious events are possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953100
Sex: F
Age: 51
State: CA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: 1/16/2021 transported to medical facility regarding the above. CBC test revealed high WBC, CT scan was negative for anything concerning. Urine test negative.

Allergies: Sulfa, benadryl

Symptoms: Severe abdominal cramps, syncope feeling, sweating, nausea, migraine, vision impairment, loose bowel movement, chills, muscle cramps

Other Meds: Ibuprofen, gabapentin

Current Illness: None

ID: 0953101
Sex: F
Age:
State: WV

Vax Date: 01/07/2021
Onset Date: 01/10/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:high

Allergies:

Symptoms: kidneys weren't acting/kidney issues; not having the feeling to urinate; Light-headed; This is a spontaneous report from a contactable consumer (reported for herself). A 91-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: EL3248; expiration date: not known), via an unspecified route of administration in the left arm on 07Jan2021 at single dose for COVID-19 immunization. Medical history included high blood pressure and blood thinner. Concomitant medication included apixaban (ELIQUIS) for blood thinner. The patient is asking if there were any reports of adverse events with kidneys and the vaccine. She received the 1st shot last Thursday (07Jan2021) and told that yesterday (10Jan2021), she had an episode where kidneys weren't acting. She also mentioned that she is on a blood thinner, ELIQUIS. She is due to receive the 2nd shot on 28Jan2021. She said that she wouldn't want to receive the 2nd dose if this was related to her adverse reaction. The issue with the kidney started after on 10Jan2021, yesterday she was really having problems, she went to church then came home by that time she would have to go to the bathroom, but she did not go, she ended up cooking dinner which was 3 hours later, she was noticing that she was not urinating. She drank some Gatorade and that made it little better, she is wondering if it's a side effect. On 10Jan2021, when she noticed the kidney issues, she did not know for certain if it started before that, she didn't pay attention. Also, yesterday (10Jan2021), she got sick in which she had to grab the counter, she felt bad, she wasn't dizzy, but felt light-headed. The symptom of not having the feeling to urinate had improved a little today but she is concerned and wanted to know if this was a side effect. Her being light-headed only occurred on 10Jan2021, it was a onetime occurrence yesterday. However, she was also just sitting around, laying around, after that yesterday. The outcome of the event 'light-headed' was unknown; while outcome of other events was recovering.

Other Meds: ELIQUIS

Current Illness:

ID: 0953102
Sex: F
Age:
State: GA

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: difficulty thinking; Extreme fatigue; dizziness; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient received her second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10Jan2021 11:15 at single dose at Arm Right for COVID-19 immunisation. Medical history included hypothyroidism, thyroid cancer, hypertension from an unknown date and ongoing, Known allergies: Latex, aluminium, nickel.The patient was not pregnant. Concomitant medication included gabapentin, propranolol, levothyroxine sodium (SYNTHROID), and pantoprazole. The patient has previously received her first dose of BNT162B2 on 20Dec2020 08:45 PM for COVID-19 immunisation at Arm left. There was no any other vaccines within 4 weeks prior to the COVID vaccine.The patient experienced difficulty thinking, extreme fatigue and dizziness resulted in Doctor or other healthcare professional office/clinic visit. All the events occurred on 11Jan2021 09:00 with outcome of recovering. No treatment was received. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.The events were considered as non-serious. Information about lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the mental impairment and other reported events due to temporal relationship. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ; ; SYNTHROID;

Current Illness: Hypertension

ID: 0953103
Sex: F
Age: 50
State: OR

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: DOCTOR ORDERED EPI PEN AND ADVISED HER TO NOT GET THE SECOND DOSE OF THE VACCINE.

Allergies: NONE

Symptoms: SEVERE SWELLING OF LEFT EYE LID AND MILD SWELLING LEFT SIDE OF HER FACE. REDNESS.

Other Meds: UNKNOWN

Current Illness: NONE

ID: 0953104
Sex: F
Age: 42
State: MI

Vax Date: 01/14/2021
Onset Date: 01/17/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies: Penicillin

Symptoms: Rt arm axillary swelling and pain. Pain is radiating down rt arm to hand. Red rash itchy rash around torso. And achy joints.

Other Meds: Ropinirole hcl

Current Illness:

ID: 0953105
Sex: U
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: concern for injection to the subcutaneous tissue/concerned about improper administration/patient has a mark where you can see the vaccine and it's higher up where you expect it to be; induration at the injection site; felt induration was moving down his/her arm/can feel it migrated down her arm, 7 inches below injection site; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK4176), subcutaneous (reported as injection to the subcutaneous tissue to deltoid) on 09Jan2021 at 0.3 mL, single to prevent from getting COVID. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on Dec2020 for COVID-19 immunization. On 09Jan2021, within a couple hours after, the patient experienced induration at the injection site. The patient felt induration was moving down his/her arm with concern for injection to the subcutaneous tissue. The patient can feel it migrated down his/her arm, 7 inches below injection site. The reporter assessed that the causality was yes for the suspect drug and the patient was concerned about improper administration. The reporter was unsure if it is administration or vaccine, the patient has a mark where you can see the vaccine and it's higher up where you expect it to be. Outcome of the vaccination site induration and induration was not recovered. The events were considered medically significant by the reporter.; Sender's Comments: Based on the available information a causal relationship between reported events induration at the injection site / induration and incorrect route (subcutaneous) of BNT162B2 vaccine administration cannot be excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953106
Sex: F
Age: 40
State: CA

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: N/A

Allergies: Benadryl Adhesive from patches

Symptoms: Patient noticed her left arm started to get swollen around 7pm, the area around the injection site was raised to approximately (at least) 1 1/2 inch; redness around the injection site was approximately 5 inches. Patient also noticed rash on the area where was red. A little later on the same day patient started to have fever, terrible body ache all over the body, joints pain, Chills, terrible headache, sore throat, cough and extreme pain on the injection site, Patient described that she was exhausted. Patient didn't take any med on 1/13/21. Patient took Motrin x 2 dose on 1/14/21 and 1 dose on 1/15/21 with no improve in all her symptoms above. Approximately in the early afternoon of 1/15/21 patient started to feel better. Patient stated she was 50% improved in her symptoms on Saturday.

Other Meds: N/A

Current Illness: N/A

ID: 0953107
Sex: F
Age:
State:

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: COVID-19; Result Unstructured Data: Test Result:Negative, PCR

Allergies:

Symptoms: Slight left sided facial weakness/droop 4 days post vaccination; Slight left sided facial weakness/droop 4 days post vaccination; Tingling in injected arm and facial tingling in cheeks/lips same day of vaccination/Tingling to lower extremities; Tingling in injected arm and facial tingling in cheeks/lips same day of vaccination; Tingling in injected arm and facial tingling in cheeks/lips same day of vaccination; This is a spontaneous report from a contactable consumer (patient herself). A 36-year-old female patient received her first dose of bnt162b2 (BNT162B2 also reported as COVID 19 brand Pfizer, lot EK9231), via an unspecified route of administration in the left arm on 04Jan2021 13:00 at single dose, for Covid-19 immunisation. The vaccine was given in a Nursing Home/Senior Living Facility. Medical history was none. No known drug allergies. No other vaccine in four weeks. No Covid-19 prior vaccination. Concomitant medication included naproxen sodium (ALEVE). The patient experienced tingling in injected arm and facial tingling in cheeks/lips same day of vaccination (04Jan2021). Tingling to lower extremities the day after vaccination (still continuing). Slight left sided facial weakness/droop 4 days post vaccination (04Jan2021). Tingling to left arm continuing on and off. No treatment reported. On 04Jan2021, she was negative to PCR covid test post vaccination. She went to the Emergency room/department or urgent care. The outcome of events was not recovered.

Other Meds: ALEVE

Current Illness:

ID: 0953108
Sex: F
Age: 42
State: OH

Vax Date: 01/08/2021
Onset Date: 01/16/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: N/a

Allergies: Sulfa

Symptoms: 1 week out symptoms started - hard lump, red, swollen, hot to touch, spread to about a 2 inch diameter

Other Meds: Women?s vitamin Meloxic

Current Illness: N/a

ID: 0953109
Sex: M
Age:
State: AL

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: BP; Result Unstructured Data: Test Result:159/94

Allergies:

Symptoms: slurring speech; rash around his neck and upper chest; his earlobes were bright red, as was his nose; mouth was dry; nose was dry; dry throat; almost "drunk"; Only abnormal finding was BP 159/94; This is a spontaneous report from contactable pharmacist. A 36-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1283 and Expiration Date unknown) via Intramuscular on 08Jan2021 11:25 at single dose for COVID-19 immunisation. The patient's medical history was reported toradol made him feel lightheaded and foggy (similar to his first Pfizer BioNTech covid vaccine), Attention deficit hyperactivity disorder (ADHD). History vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number =EK5730 and Expiration Date unknown) via Intramuscular on 18Dec2020 at single dose for COVID-19 immunisation. Patient did report that on first vaccine it made him feel a little sluggish, tired and foggy minded. The concomitant medications were reported as amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (Adderall XR) at 25mg twice a day (BID) and escitalopram oxalate (LEXAPRO) oral (PO) at 10mg every day. No other vaccine in four weeks. Patient was vaccinated at 11:25. Patient was observed for 30 minutes. Pharmacist checked on patient at 17 minutes after vaccination - he was fine able to communicate and showed no signs of distress. Pharmacist came back and checked on patient at 25 minutes after vaccination (11:50) and patient was slurring speech, had developed rash around his neck and upper chest, his earlobes were bright red, as was his nose - mouth was dry, reported dry throat - no visible swelling of the lips or tongue. Patient was transported to ED (2 min) Home meds: Adderall XR 25mg BID [Twice a day], Lexapro 10mg Q [every]PM. Only abnormal finding was BP 159/94 - after initial workup patient was noted to be almost "drunk" as reported by Emergency Room (ER Doc). Patient was offered diphenhydramine declined several times but eventually agreed. Approx 30 min after diphenhydramine patient fully recovered and stated "I'm back". The second dose reaction was much more exaggerated and lasted much longer. No COVID prior vaccination and no COVID tested post vaccination. The adverse event result in Emergency room/department or urgent care. The outcome of events was recovered in Jan2021 after treatment was given.; Sender's Comments: Based on the time association, all events are possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: LEXAPRO; ADDERALL

Current Illness:

ID: 0953110
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital: Y

Lab Data: Test Name: acute onset of fever; Result Unstructured Data: Test Result:101.2; Test Name: BNP; Result Unstructured Data: Test Result:No evidence of myocardial damage or CHF based on B; Comments: No evidence of myocardial damage or CHF based on BNP and troponin, respectively; Test Name: crx; Result Unstructured Data: Test Result:bilateral vascular congestion; Test Name: eosinophilia; Result Unstructured Data: Test Result:no; Test Name: Troponin; Result Unstructured Data: Test Result:No evidence of myocardial damage or CHF based on B; Comments: No evidence of myocardial damage or CHF based on BNP and troponin, respectively; Test Name: leukocytosis; Result Unstructured Data: Test Result:17,800

Allergies:

Symptoms: SOB; leukocytosis; acute onset of fever (101.2); CXR = bilateral vascular congestion; This is a spontaneous report from a contactable consumer. An elderly NH resident patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date, at single dose, for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date the patient experienced shortness of breath (SOB), leukocytosis (17,800), acute onset of fever (101.2), bilateral vascular congestion. The patient was admitted with acute onset of fever (101.2), leukocytosis (17,800, no eosinophilia) and SOB, all beginning 3-4 hours after BNT162B2 administration. CXR showed bilateral vascular congestion. No facial or SQ edema. No evidence of myocardial damage or CHF based on BNP and troponin, respectively. The patient was treated with brief (3 days) pulse of methylprednisolone sodium succinate (SOLUMEDROL) with improvement. Chalking it up to acute capillary leak syndrome 2^2 vaccine. The final events outcome was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness: Living in nursing home

ID: 0953111
Sex: F
Age:
State:

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Blood in stool; Fever; Night sweats; Chills; Ache; This is a spontaneous report from a contactable physician reporting for herself. An adult (reported as 30-something year old) female patient received the 1st dose of bnt162b2 (BNT162B2), via an unspecified route of administration, on 30Dec2020, at single dose, for COVID-19 immunisation. The patient's medical history was none. Concomitant medications were not reported. The patient experienced blood in stool in Jan2021 with outcome of unknown, chills on 31Dec2020 with outcome of unknown, ache on 31Dec2020 with outcome of unknown, fever in Jan2021 with outcome of unknown, night sweats in Jan2021 with outcome of unknown. The patient reported that 24 hours after vaccination she experienced chills and aches, and after the 24 hours experienced some significant fevers that wouldn't break and chills. Then, after about 2 hours, the fever would break and come back and it was like a cycle. Also had night sweats and blood in her stools after that. The information on the lot/batch number has been requested.; Sender's Comments: The female patient received the 1st dose of bnt162b2 (BNT162B2) on 30Dec2020, and experienced blood in stool in Jan2021 with outcome of unknown. The information available is limited, and case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0953112
Sex: F
Age: 61
State:

Vax Date: 01/07/2021
Onset Date: 01/14/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: A 61-year-old female presents for evaluation and treatment of a pruritic rash at the site of her recent covid-19 vaccination. Was given on 01/07 and she initially had some arm soreness as well as irritation. That resolved but several days ago developed a pruritic rash around the site along with some irritated lymphadenopathy on the left axilla. She denies any nausea vomiting, anxiety, globus sensation or respiratory symptoms. Recommend cetirizine or loratadine 10 mg daily, triamcinolone topically twice a day. Given affected has been steadily increasing last couple of days a Medrol Dosepak was prescribed.

Other Meds:

Current Illness:

ID: 0953113
Sex: F
Age: 61
State: NE

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: None

Allergies: None

Symptoms: Temp off 100.8 at 0430 on 1-12-2021. Chills at that time, body aches. No appetite at 0900 on 1-12-2021 and no energy for rest of the day. Nauseated thru out day. Muscle aches thru out day. No further temp by 1700 on that day. On 1-15-2021 noticed redness and itching at injection site...prior to that arm was just sore-also had cough worsen on 1-12-2021. I have had cough off and on since my positive Covid in December

Other Meds: Vitamin, calcium and vitamins D supplements, baby ASA

Current Illness: Had positive Covid Dec 21, 2020

ID: 0953114
Sex: F
Age: 24
State: TX

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: The following two days, I had a migraine. I also had swelling and tenderness at the vaccination site for 6 days afterwards.

Other Meds:

Current Illness:

ID: 0953115
Sex: F
Age: 37
State: PA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: NA

Allergies: None known

Symptoms: 1/15/2021 minor aches, Saturday 1/16 started with chills, fever, headache and low grade fever around 6AM. Body aches and fatigue on Sunday 1/17and Monday 1/18

Other Meds: none

Current Illness: none

ID: 0953116
Sex: M
Age: 79
State: DC

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: NA

Allergies: florinated steroids

Symptoms: Vaccine at 10:45 am. At 2 am patient awoke with severe chest, left arm, back of the head, neck, stomach and shoulder pain and was breathing heavily, in a panic attack. Said he feared he was having a heart attack. I gave him an extra strength tylenol, rubbed his neck, back of head, shoulders and suggested he was having a vaccine reaction. After about an hour, he fell asleep. He awoke around 8:30 am with a slight headache but otherwise feeling fine.

Other Meds: celebrex lipitor nexium tylenal lexapro

Current Illness: NA

ID: 0953117
Sex: F
Age: 33
State: CA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: None

Allergies: None that I am aware of

Symptoms: A rash appeared on the upper left leg about 5-10 minutes after the vaccine was administered. A slight burning/stinging sensation was experienced during the 15 minute observation period after vaccine administration; however, at the time, this was attributed to warmth from sitting in the sun. After return to work, the rash was noticed during a bathroom break, which spanned the entirety of the front of the upper left leg. A significant amount of nausea was also experienced about an hour after vaccine administration; however, it stopped short of vomiting. The rash lessened throughout the day and was nearly gone by the end of the night. The nausea also subsided around 6 pm. Only mild flu-like symptoms were experienced the following day (headache, fatigue, head congestion), which were ameliorated 48 hrs post vaccine administration. Pain in the left arm was also experienced, which peaked 24 hours after vaccine administration and subsided 48 hours after.

Other Meds: Birth control, bupropion, l-theanine supplement

Current Illness: None

ID: 0953118
Sex: F
Age: 35
State: IL

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: covid rapid done on wed 1/6/21

Allergies: na

Symptoms: diagnosed with covid after close exposure realized- sitter tested positive

Other Meds: prenatal vitamin, zyrtec, flonase

Current Illness: na

ID: 0953119
Sex: F
Age: 42
State: WI

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Patient seen for pre-scheduled labs on day following the events.

Allergies: Sulfa, buspar.

Symptoms: 17 minutes after injection, . Moved to a clinical room. BP initially elevated and tachycardic. Respiratory rate and pulse ox normal. Patient given oral Benadryl, IM epi and IV Solu-medrol. HR slowed and patient became hypotensive. IV fluids initiated. Patient observed for a couple of hours and discharged home. Patient called her allergist who initiated steroids and continuous histamine blockers.

Other Meds: alprazolam, cetirizine, vitamin D. fluticasone, gabapentin, atrovent, multi vitamin, Omega-3 fatty acid.

Current Illness: Conjunctivitis.

ID: 0953120
Sex: M
Age: 45
State: OH

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: NONE

Allergies: NONE

Symptoms: TOOK IBUPROFEN BEFORE GETTING VACCINE AND AROUND 0230 AM WOKE UP WITH CHILLS THAT LASTED UNTIL MORNING AND AS THE DAY WENT ON HAD GENERAL MALAISE/BODY ACHES.

Other Meds: NONE

Current Illness: NONE

ID: 0953121
Sex: M
Age: 37
State: AZ

Vax Date: 01/11/2021
Onset Date: 01/13/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies: None

Symptoms: Shoulder tendinitis

Other Meds: None

Current Illness: None

ID: 0953122
Sex: F
Age: 82
State: CA

Vax Date: 01/16/2021
Onset Date: 01/18/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: No medical or lab tests.

Allergies: Z-pack

Symptoms: There is a red lump. 1 1/2 inches wide and 1 inch tall. It feels warm to the touch. No treatment has been administered.

Other Meds: Valsartan, Tolterodine Tart, Triamterene, Levothyroxine, Famotidine, Calcium, Vitamin C and Multi-vitamin.

Current Illness: None

ID: 0953123
Sex: F
Age: 34
State: CA

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: no

Allergies: none

Symptoms: At 1:00 - 3:00 in morning - 100.3 temperature and chills and headache. Headache became severe - 7:00 in morning. Really severe joint pain and headache - not quite a migraine - no aura but very severe headache. Had to medicate with 1000 mg Tylenol and 600 of Advil. Headache for days. Pain at injection site and that has been with every vaccine I've ever had. Headache went away within three or four days. Joint pain was there for about two days. Only medicated the headache the first couple of days then it slowly got better. Didn't get vertigo and didn't get flushed after the vaccine. Didn't have the fainting feeling.

Other Meds: Vit D; calcium

Current Illness: Migraine

ID: 0953124
Sex: F
Age: 50
State: MO

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever 101.3, chills, headache, extreme fatigue, soreness at injection site

Other Meds:

Current Illness:

ID: 0953125
Sex: M
Age: 48
State: WI

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data: COVID-19-negative

Allergies: latex, penicillin

Symptoms: After the injection my arm got really sore. I began to feel really tired and begin to have chills and shakes. I started having diarreah and began throwing up. I had a sever headache and body aches which all symptoms lasted for about 3 days and I felt so bad so on Wed 12/30 I went to Urgent Care and was given fluids which did make me begin to feel a little better. On Monday I was sent for a COVID test which was negative. On Friday 1/1 i was finally able to return back to work.

Other Meds: no

Current Illness: no

ID: 0953126
Sex: F
Age: 53
State: OH

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies: Sensitivity to wheat, red food dye #40

Symptoms: Moderna COVID-19 Vaccine EUA received on Saturday. Sunday morning in the middle of my sleep, I woke feeling hot and sweaty, slightly nauseated, and like I had to defecate. I stood up, felt like low blood pressure but wanted to get to the bathroom. I walked towards the door, opened the door and fainted, falling backwards. My spouse states I was pale,staring at the ceiling and kind of stiff in my arms and legs for about 3 minutes. He spoke to me, checked my pulse, covered me, poked my feet. As I came back to awareness I tried to speak and was unintelligible but then became more conscious. He tested me with questions to make sure I was ok. I defecated after that but did not vomit. I was tired the rest of the day and napped for several hours. I don't seem to have hurt anything in the fall. I am instructed to be off work Monday by my supervisor.

Other Meds: Levothyroxine, sertraline, calcium and vit D, Claritin, turmeric, zinc

Current Illness: Covid-19 starting date 12/19/2020

ID: 0953127
Sex: M
Age: 59
State: NC

Vax Date: 12/16/2020
Onset Date: 12/16/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue, malaise, aches and pain. Mainly at injection site. Just took sick leave for the day.

Other Meds: Atoristantin (lipid lowering agent) Lonaise Aspirin Zyrtec

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm